Dr. Bambot is a biomedical engineer with over 20 years of experience in developing innovative medical devices, business development, intellectual property development, regulatory strategy and clinical trials. He is currently cofounder and CTO at LumaMed, LLC, a company focused on developing imaging devices to help surgeons see cancer margins during surgery. He previously cofounded Guided Therapeutics, a company developing products for non-invasive and point of care cancer diagnosis. He has helped launch a number of innovative medical products, the AVL/Roche OPTI 2® blood chemistry analyzer, the SpectRx BiliChek® Non-invasive Bilirubin Analyzer and the Guided Therapeutics LuViva® Advanced Cervical Scan. He is a named inventor on 10 (ten) US patents and several additional applications. He has several publications in the areas of clinical monitoring and diagnostics and is the recipient of multiple NIH SBIR grants totaling in excess of $6.5 million for developing non-invasive diagnostic devices. He frequently serves on review panels for scientific publications and NIH grant applications.